Related Experiment Video
Updated: Nov 3, 2025
08:19
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
18.2K
Preclinical Evaluation of Lipid-Based Nanosystems
Ana Catarina Silva1,2, José Manuel Sousa Lobo1
1UCIBIO/REQUIMTE, MEDTECH, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Pharmaceutics
|June 2, 2021
Summary
Lipid-based nanosystems like lipid nanoparticles (SLN, NLC), nanoemulsions, and liposomes are widely used in various applications. These advanced delivery systems offer significant potential for drug development and beyond.
Area of Science:
- Nanotechnology and Materials Science
- Pharmaceutical Sciences
- Biomedical Engineering
Background:
- Lipid-based nanosystems are crucial in modern drug delivery.
- Examples include solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), nanoemulsions, and liposomes.
- Their versatility drives innovation across multiple scientific fields.
Discussion:
- The broad applicability of lipid nanosystems necessitates a comprehensive understanding of their properties.
- Exploring the nuances of SLN and NLC is key to optimizing formulation design.
- Nanoemulsions and liposomes represent distinct yet valuable approaches within lipid-based delivery.
Key Insights:
- Lipid nanoparticles (SLN, NLC), nanoemulsions, and liposomes are foundational to advanced delivery systems.
- These systems are integral to the development of novel therapeutics.
- Their widespread use underscores their importance in pharmaceutical research.
Outlook:
- Further research into lipid nanosystem optimization is expected.
- New applications for SLN, NLC, nanoemulsions, and liposomes will likely emerge.
- Advancements in lipid-based delivery will continue to impact medicine and biotechnology.
